Iopamidol and Conray 60: comparison in superselective angiography.
Iopamidol (280 mgI/ml) was compared with Conray 60 (iothalmate meglumine, 282 mgI/ml) during selective and superselective cerebral arteriography. Twelve patients were examined, and a total of 51 selective injections were compared. Iopamidol produced significantly less pain and burning than Conray 60 and caused no patient motion.
D000328:Adult; D000368:Aged; D002533:Cerebral Angiography / Q000379:methods*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005153:Facial Neoplasms / Q000000981:diagnostic imaging; D005260:Female; D006391:Hemangioma / Q000000981:diagnostic imaging; D006801:Humans; D002538:Intracranial Arteriovenous Malformations / Q000000981:diagnostic imaging; D007479:Iopamidol; D007482:Iothalamate Meglumine / Q000009:adverse effects; D007483:Iothalamic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D008297:Male; D008577:Meningeal Neoplasms / Q000000981:diagnostic imaging; D008579:Meningioma / Q000000981:diagnostic imaging; D008875:Middle Aged
D007483:Iothalamic Acid; D007479:Iopamidol; D007482:Iothalamate Meglumine